Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Verisys introduces new online credentialing system
The new system can be accessed through any computer, tablet or smartphone, the company said. CheckMedic helps healthcare organizations by checking and verifying the credentials, background data and
The new system can be accessed through any computer, tablet or smartphone, the company said. CheckMedic helps healthcare organizations by checking and verifying the credentials, background data and
HuMax-TF is a fully human antibody targeted to tissue factor (TF), a protein involved in tumor signaling and angiogenesis. As per the deal, Genmab gets development and cGMP
NGR-hTNF is a vascular targeting agent belonging to peptide/cytokine complexes, which can selectively target the tumour vasculature. The randomised, double-blind, placebo-controlled, multicentre Phase III NGR015 trial, will enroll
The double-blind, randomized, placebo-controlled dose-ranging study, assessed the pharmacokinetics, safety and tolerability of BAL30072 in healthy volunteers following multiple ascending doses of intravenous infusions. The trial demonstrated that
AB103 is a short peptide acting as a CD28 modulator which regulates the inflammatory response in the host. The drug candidate is said to have completed a phase
ProBioGen’s GlymaxX ADCC enhancement technology, mammalian cell line development and manufacturing services will be employed to advance therapeutic antibodies developed by Inhibrx. Under the terms of the collaboration,
AP301, an orally inhaled drug candidate is used against respiratory failure caused by pulmonary oedema that activates lung oedema reabsorption. The Phase I single-center clinical trial assessed the
Two-thirds of the enrolled patients were less than four years old. Shigamabs consists of two monoclonal antibodies which bind to the Shiga toxin 1 and Shiga toxin 2
As part of the acquisition, Biostar has changed its name to Shaanxi Weinan Aoxing Pharmaceuticals. Next to the acquisition, Biostar has increased its portfolio of drug approvals and
Rivastigmine Capsules are the generic forms of Novartis’ Exelon Capsules. Mylan chairman and CEO Robert Coury said they are excited to be adding generic Rivastigmine to their portfolio